icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, metforminas hidrochloridas - cukrinis diabetas, 2 tipas - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ir 5. 1, jei yra duomenų apie skirtingus derinius).
teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - skrandžio navikai - antinavikiniai vaistai - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
diompraz
bausch health ireland limited - diklofenako natrio druska/omeprazolas - modifikuoto atpalaidavimo kietosios kapsulės - 75 mg/20 mg - diclofenac, combinations
xalopticom
zakłady farmaceutyczne polpharma s.a. - latanoprostas/timololis - akių lašai (tirpalas) - 50 µg/5 mg/ml - timolol, combinations
aduzin
sandoz d.d. - dutasteridas/tamsulozino hidrochloridas - kietosios kapsulės - 0,5 mg/0,4 mg - tamsulosin and dutasteride
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetilfumaratas - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantai - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
tafinlar
novartis europharm limited - dabrafenib mesilate - melanoma - antinavikiniai vaistai - melanomadabrafenib as monotherapy or in combination with trametinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutation (see sections 4. 4 ir 5. oksaliplatina melanomadabrafenib kartu su trametinib yra nurodyta, kad oksaliplatina suaugusiems pacientams, sergantiems iii stadijos melanoma su braf v600 mutacija, taip užbaigti rezekcija. non-small cell lung cancer (nsclc)dabrafenib in combination with trametinib is indicated for the treatment of adult patients with advanced non-small cell lung cancer with a braf v600 mutation.
amiptic
pharmaceutical works polpharma s.a. - dorzolamidas/timololis - akių lašai (tirpalas) - 20 mg/5 mg/ml - timolol, combinations
amiptifree
pharmaceutical works polpharma s.a. - dorzolamidas/timololis - akių lašai (tirpalas) - 20 mg/5 mg/ml - timolol, combinations
brimonidine/timolol pharmaswiss
pharmaswiss Česká republika s.r.o. - brimonidino tartratas/timololis - akių lašai (tirpalas) - 2 mg/5 mg/ml - timolol, combinations